Esperite 's R&D Division "The Cell Factory" implements GMP Stem Cell Bioproduction Technology and aims the Cerebral Palsy as first clinical trial.
September 25, 2014 01:47 ET
|
Esperite N.V.
PRESS RELEASEZutphen, The Netherlands, 25 September 2014 Esperite (Euronext.: ESP), the European leader in stem cells cryopreservation now entering the fields of predictive medicine and...
PKC GROUP PLC'S FINANCIAL REPORTING AND ANNUAL GENERAL MEETING IN 2015
September 25, 2014 01:45 ET
|
PKC Group Oyj
PKC Group Plc Company Announcement 25 September 2014 8:45 am
PKC GROUP PLC'S FINANCIAL REPORTING AND ANNUAL GENERAL MEETING IN 2015
PKC...
Revolutionary Mosquito technology revealed at BIMobject® LIVe
September 25, 2014 01:42 ET
|
BIMobject AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BIMobject® will announce a new technology...
BIMobject Open Property Cloud revealed at BIMobject® LIVe
September 25, 2014 01:32 ET
|
BIMobject AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BIMobject® will announce the...
BW Offshore: Mandatory notification of trade
September 25, 2014 01:30 ET
|
BW Offshore
Ståle Andreassen, SVP Finance in BW Offshore, yesterday purchased 132,000 shares in BW Offshore Limited of NOK 7.51 per share. Following this transaction, Mr. Andreassen holds 850,000 shares in BW...
INNATE PHARMA: Third DSMB for EffiKIR trial recommends continuation as planned
September 25, 2014 01:30 ET
|
INNATE PHARMA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Marseille, France, September 25, 2014 Innate...
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR) - Net Asset Value(s)
September 25, 2014 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP) - Net Asset Value(s)
September 25, 2014 01:27 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Novartis AIN457 (secukinumab) is the first ever IL-17A inhibitor to meet primary endpoint in two Phase III studies in psoriatic arthritis
September 25, 2014 01:15 ET
|
Novartis Pharma AG
Secukinumab met primary and key secondary endpoints in two pivotal Phase III studies showing superiority to placebo in patients with adult onset psoriatic arthritis (PsA) PsA is a debilitating,...
IT – Genium INET Test – Disturbance External Test System 4
September 25, 2014 01:12 ET
|
Fixed Income
We are currently experiencing a disturbance on External Test System 4.
Impact
External Test System 4 is currently unavailable for all testing.
Contact
If you have any questions in regards...